Thrombopoietins and thrombopoiesis: A clinical perspective

Vox Sanguinis

Volumn 74, Issue SUPPL. 2, 1998, Pages 75-85

  Kuter, D J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; RECOMBINANT THROMBOPOIETIN; THROMBOPOIETIN;

BLOOD TRANSFUSION; CONFERENCE PAPER; HUMAN; MEGAKARYOCYTE; PRIORITY JOURNAL; STEM CELL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPOIESIS;

EID: 0031824101     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1998.tb05400.x     Document Type: Conference Paper

References (43)

1. Duke WW: The relationship of blood platelets to hemorrhagic disease: description of a method for determining the bleeding time and coagulation time. JAMA 1910;55:1185-1192.
2. Wallace EL, Churchill WH, Surgenor DM, An J, Cho G, McGurk S, Murphy L: Collection and transfusion of blood and blood components in the United States, 1992. Transfusion 1995;35:802-812.
3. Devine P, Goldstein R, Linden JV, Postoway N, Hoffstadter LK, Hines DM: Data on apheresis, blood collection, and transfusion-related activities: statistical analyses of the AABB institutional membership questionnaires. Transfusion 1996;36:375-381.
4. Wright JH: Differential staining of blood films and malarial parasites. J Medical Res 1902;7:138-144.
5. Wright JH: The origin and nature of blood plates. Boston Medical and Surgical Journal 1906;154:643-645.
6. Wright JH: The histogenesis of the blood platelets. J Morph 1910;21:263-278.
7. Kelemen E, Cserhati I, Tanos B: Demonstration and some properties of human thrombopoietin in thrombocythaemic sera. Acta Haematol 1958;20:350-355.
8. Kato, T, Ogami K, Shimada Y, Iwamatsu A, Sohma Y, Akahori H, Horie K, Kokubo A, Kudo Y, Maeda E, Kobayashi K, Ohashi H, Ozawa T, Inoue H, Kawamura K, Miyazaki H: Purification and characterization of thrombopoietin. J Biochem 1995;119:229-236.
9. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, Grant FJ, Helpel MD, Burkhead SK, Kramer JM, Bell LA, Sprecher CA, Blumberg H, Johnson R, Prunkard D, Ching AFT, Mathewes SL, Bailey MC, Forstrom JW, Buddle MM, Osborn SG, Evans SJ, Sheppard PO, Presnell SR, O'Hara PJ, Hagen FS, Roth GJ, Foster DC: Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
10. de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang W, Oles KJ, Hultgren B, Solberg LA, Goeddel DV, Eaton DL: Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
11. Bartley TD, Bogenberger J, Hunt P, Li YS, Lu HS, Martin F, Chang MS, Samai B, Nichol JL, Swift S, Johnson MJ, Hsu RY, Parker VP, Suggs S, Skrine JD, Merewether LA, Clogston C, Hsu E, Hokom MM, Hornkohl A, Choi E, Pangelinan M, Sun Y, Mar V, McNinch J, Simonet L, Jacobsen F, Xie C, Shutter J, Chute H, Basu R, Selander L, Trollinger D, Sieu L, Padilla D, Trail G, Elliott G, Izumi R, Covey T, Crouse J, Garcia A, Xu W, Del Castillo J, Biron J, Cole S, Hu MCT, Pacifici R, Ponting I, Saris C, Wen D, Yung YP, Lin H, Bosselman RA: Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
12. Kuter DJ, Beeler DL, Rosenberg RD: The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci (USA) 1994;91:11104-11108.
13. Souryi M, Vignon I, Penciolelli J-F, Heard JM, Tambourin P, Wendung F: A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors. Cell 1990;63:1137-1147.
14. Vignon I, Mornon J-P, Cocault L, Mitjavila M-T, Tambourin P, Gisselbrecht S, Souyri M: Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: Identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sci (USA) 1992;89:5640-5644.
15. Gin JG, Smith WG, Kahn LE, Streeter P, Minster N, Baum C, Lind L, Farese AM, Lin J, Roecklein B, MacVittie TJ, McKearn J: Promegapoietin, a chimeric growth factor for megakaryocyte and platelet restoration. Blood 1997;90 (Suppl), 580a.
16. Cwirla SE, Balasubramanian P, Duffin DJ, Wagstrom CR, Gates CM, Singer SC, Davis AM, Tansik RL, Mattheakis LC, Boytos CM, Schatz PJ, Baccarini DP, Wrighton NC, Barrett RW, Dower WJ: Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine. Science 1997;276:1696-1699.
17. Kuter DJ, Hunt P, Sheridan WP, Zucker-Franklin D (eds): Thrombopoiesis and Thrombopoietins: Molecular, Cellular, Preclinical, and Clinical Biology. Humana Press, Totowa, New Jersey, 1997.
18. Alexander WS, Metcalf D, Dunn AR: Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 1995;14:5569-5578.
19. Harker LA, Hunt P, Marzec UM, Kelly AB, Tomer A, Hanson SR, Stead RB: Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 1996;87:1833-1844.
20. Tomita D, Petrarca M, Paine T, Olson K, Roskos L, Cheung E: Effect of a single dose of pegylated human recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet counts: implications for platelet apheresis. Transfusion 1997;37 (Suppl 1):2S.
21. Gurney AL, Carver-Moore K, de Sauvage FJ, Moore MW: Thrombocytopenia in c-Mpl-deficient mice. Science 1994;265:1445-1447.
22. de Sauvage FJ, Carver-Moore K, Luoh S-M, Ryan A, Dowd M, Eaton DL, Moore MW: Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996;183:651-656.
23. Carver-Moore K, Broxmeyer HE, Luoh S-M, Cooper S, Peng J, Burstein SA, Moore MW, de Sauvage FJ: Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood 1996;88:803-808.
24. Fanucci M, Glaspy J, Crawford J, Garst J, Figlin R, Sheridan W, Menchaca D, Tomita D, Ozer H, Harker L: Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New Engl J Med 1997;336:404-409.
25. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Grigg AP, Zalchberg J, Cohen B, O'Byrne J, Menchaca DM, Fox RM, Begley CG: Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 1997;89:3118-3128.
26. Vadhan-Raj S, Verschraegen C, McGarry L, Bueso-RAmos C, Kudelka A, Freedman R, Edwards C, Severs M, Levenback C, Gershenson D, Jones D, Yang T, Bast RC, Kavanaugh J: Recombinant human thrombopoietin (rhTPO) attenuates high-dose carboplatin (C)-induced thrombocytopenia in patients with gynecological malignancy. Blood 1997;90 (Suppl):580a.
27. Fibbe WE, Heemskerk DPM, Laterveer L, Pruijt JFM, Foster D, Kaushansky K, Willemze R: Accelerated reconstitution of platelets and erythrocytes after syngeneic transplantation of bone marrow cells derived from thrombopoietin pretreated donor mice. Blood 1995;86:3308-3313.
28. Beveridge R, Schuster M, Waller E, Stuart R, Abboud C, Cruickshank S, Menchaca D, Macri M, Connaghan DG: Randomized, double-blind, placebo-controlled trial of pegylated recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients following autologous bone marrow transplantation. Blood 1997;90 (Suppl):580a.
29. Kuter DJ: Thrombopoietin: biology and clinical applications. The Oncologist 1996;1:98-106.
30. Ballmaier M, Schulze H, Straub G, Cherkaoui K, Wittner N, Lynen S, Wolters S, Bogenberger J, Weite K: Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood 1997;90:612-619.
31. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter SJ: Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. J Clin Invest 1987;80:33-40.
32. Aster RH: Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest 1966;45:645-657.
33. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M: Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:2644-2653.
34. Choi ES, Nichol JL, Hokom MM, Homkohl AC, Hunt P: Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995;85:402-413.
35. Goodnough LT, DiPersio J, McCullough J, Peterson R, Armstrong S, Menchaca D, Tomita D, Romo J, Kuter D: Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases platelet (PLT) count (CT) and apheresis yields of normal PLT donors: initial results. Transfusion 1997;37(Suppl.1):266S.
36. Kuter D, McCullough J, Romo JD, DiPersio J, Peterson R, Armstrong S, Menchaca D, Tomita D, Goodnough LT: Treatment of platelet (PLT) donors with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases circulating PLT counts (CTS) and PLT apheresis yields and increases platelet increments in recipients of PLT transfusions. Blood 1997;90(Suppl):579a.
37. Vigon I, Dreyfus F, Melle J, Viguie F, Ribrag V, Cocault L, Souryi M, Gisselbrecht S: Expression of the c-mpl proto-oncogene in human hematologic malignancies. Blood 1993;82:877-883.
38. Columbyova L, Loda M, Scadden DT: Thrombopoietin receptor expression in human cancer cell lines and primary tissues. Cancer Research 1995;55:3509-3512.
39. Van X-Q, Lacey D, Fletcher F, Hartley C, McElroy T, Sun Y, Xia M, Mu S, Saris C, Hill D, Hawley RG, McNiece I: Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice. Blood 1995;86:4025-4033.
40. Harker LA, Marzec UM, Hunt P, Kelly AB, Tomer A, Cheung E, Henson SR, Stead RB: Dose-response effects of pegylated megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996;88:511-521.
41. Du X, Williams DA: Interleukin-11: Review of molecular, cell biology, and clinical use. Blood 1997;89:3897-3908.
42. Tepler I, Elias L, Smith JW, Hussein M, Rosen G, Chang AY, Moore JO, Gordon MS, Kuca B, Beach KL, Loewy JW, Garnick MB, Kaye JA: A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996;87:3607-3614.
43. MacVittie TJ, Farese AM, Lind LB, Smith WG, Streeter P, McKearn JP: Progenipoietin-G stimulates hematopoietic recovery following myelosuppression. Blood 1997;90(Suppl):581a.